266 related articles for article (PubMed ID: 24991000)
41. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
[TBL] [Abstract][Full Text] [Related]
42. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
Yoshida T; Koyanagi Y; Strebel K
J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
[TBL] [Abstract][Full Text] [Related]
43. Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR
J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741
[TBL] [Abstract][Full Text] [Related]
44. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
45. Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.
Stansell E; Desrosiers RC
J Virol; 2010 Sep; 84(18):8998-9009. PubMed ID: 20610711
[TBL] [Abstract][Full Text] [Related]
46. Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms.
Gallay PA; Ptak RG; Bobardt MD; Dumont JM; Vuagniaux G; Rosenwirth B
Viruses; 2013 Mar; 5(3):981-97. PubMed ID: 23524389
[TBL] [Abstract][Full Text] [Related]
47. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
48. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
Hulme AE; Kelley Z; Okocha EA; Hope TJ
J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
[TBL] [Abstract][Full Text] [Related]
49. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.
Li Y; Li X; Stremlau M; Lee M; Sodroski J
J Virol; 2006 Jul; 80(14):6738-44. PubMed ID: 16809279
[TBL] [Abstract][Full Text] [Related]
50. Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity.
Obr M; Hadravová R; DoleŽal M; KříŽová I; Papoušková V; Zídek L; Hrabal R; Ruml T; Rumlová M
Retrovirology; 2014 Oct; 11():94. PubMed ID: 25365920
[TBL] [Abstract][Full Text] [Related]
51. Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.
Postler TS; Martinez-Navio JM; Yuste E; Desrosiers RC
J Virol; 2012 Jan; 86(2):1145-57. PubMed ID: 22072749
[TBL] [Abstract][Full Text] [Related]
52. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
[TBL] [Abstract][Full Text] [Related]
53. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
[TBL] [Abstract][Full Text] [Related]
54. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
Schaller T; Ylinen LM; Webb BL; Singh S; Towers GJ
J Virol; 2007 Sep; 81(18):10055-63. PubMed ID: 17609268
[TBL] [Abstract][Full Text] [Related]
55. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
56. Gene loss and adaptation to hominids underlie the ancient origin of HIV-1.
Etienne L; Hahn BH; Sharp PM; Matsen FA; Emerman M
Cell Host Microbe; 2013 Jul; 14(1):85-92. PubMed ID: 23870316
[TBL] [Abstract][Full Text] [Related]
57. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
Burse M; Shi J; Aiken C
PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
[TBL] [Abstract][Full Text] [Related]
58. Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner.
Zhong Z; Ning J; Boggs EA; Jang S; Wallace C; Telmer C; Bruchez MP; Ahn J; Engelman AN; Zhang P; Watkins SC; Ambrose Z
mBio; 2021 Mar; 12(2):. PubMed ID: 33758083
[TBL] [Abstract][Full Text] [Related]
59. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
[TBL] [Abstract][Full Text] [Related]
60. TRIM5α Restriction of HIV-1-N74D Viruses in Lymphocytes Is Caused by a Loss of Cyclophilin A Protection.
Selyutina A; Simons LM; Kirby KA; Bulnes-Ramos A; Hu P; Sarafianos SG; Hultquist JF; Diaz-Griffero F
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
